SCHEMBL4013561

SCHEMBL4013561

O=c1[nH]c(=O)c2[nH]c(CCCc3cnn(Cc4cc(Cl)ccc4Cl)c3)nc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 5/20 0.42
ADORA2A P29274 4/20 0.42
ADORA1 P30542 4/20 0.42
ROCK2 O75116 1/20 0.33
PIM1 P11309 1/20 0.33
GSK3B P49841 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TUBB4A P04350 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5685358 0.89 ADORA2B (0.45) ADORA2BADORA2AADORA1ADORA3MEN1
SCHEMBL4320462 0.81 ADORA2B (0.41) ADORA2BADORA2AADORA1ADORA3
SCHEMBL5608377 0.77 ADORA2B (0.50) ADORA2BADORA2AADORA1ADORA3HTT
SCHEMBL5685510 0.74 ADORA2B (0.49) ADORA2BADORA2AADORA1ADORA3
SCHEMBL1720832 0.70 ADORA2B (0.37) ADORA2BGSK3BMEN1KMT2AMAPT
SCHEMBL1943365 0.67
SCHEMBL16099460 0.66 ADORA2B (0.50) ADORA2BADORA2AADORA1ADORA3MEN1
SCHEMBL15642930 0.64 HCAR2 (0.43) ADORA2BADORA2AADORA1ADORA3MAPT
SCHEMBL1946781 0.62 ADORA2B (0.67) ADORA2BADORA2AADORA1ADORA3
SCHEMBL6233162 0.62 XDH (0.51) ADORA2BGSK3BMAPTMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009157938-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER CV THERAPEUTICS, INC. (US) 2009-12-30 WO disclosed
WO-2009088518-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER CV THERAPEUTICS, INC. (US) 2009-07-16 WO disclosed